For the first time ever, the International Conference on Miniaturized Systems for Chemistry and Life Sciences (microTAS) will be held in Australia. The 29th microTAS 2025 meeting takes place at the Adelaide Convention Centre from November 2 to 6. This conference is the leading forum for microfluidics, lab-on-a-chip, organ-on-a-chip, BioMEMS, nanotechnology, and related fields.
As a lab dedicated to developing miniature systems and devices for chemistry and life sciences, this conference means a lot to us. We are proud to announce that five abstracts from Shiddiky Laboratory (https://shiddiky.com/) have been accepted for microTAS 2025 in Adelaide. This includes four posters and one oral presentation.
The research highlights are:
Fatema Zerin Farhana will present a new surface-enhanced Raman scattering (SERS) platform that detects microRNAs without amplification, offering a faster and more accurate alternative to PCR. This method uses gold nanoparticles to identify cancer-related microRNAs with high sensitivity, paving the way for affordable, point-of-care cancer diagnostics.
Sharmin Aktar and Milkiyas Toru Tantu will present RareSwitch-LAMP, a method that detects rare colorectal cancer mutations in just 40 minutes. This approach can also be adapted for other diseases, making fast and precise genetic testing more accessible.
Kiran Shrestha’s handheld device, PEARL-B, detects breast cancer biomarkers from a single drop of sample in five minutes. It connects to a smartphone and works without complex lab equipment, aiming to make early breast cancer screening quicker and more affordable.
Farjana Haque will present an amplification-free electrochemical sensor for detecting the plant pathogen Xylella fastidiosa from xylem sap. This simple and sensitive method offers a practical solution for early plant disease detection and biosecurity surveillance.
Finally, M A Shaon will deliver his first oral presentation on ExoPorous, an integrated platform for direct, extraction-free detection of placental exosomal mRNA linked to preeclampsia. This user-friendly and low-cost test has the potential to improve early, non-invasive pregnancy complication screening.
Congratulations to the team and all co-authors for these fantastic achievements.
We look forward to connecting with the global microTAS community in Adelaide!